PNC Financial Services Group’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.75K | Sell |
244
-34
| -12% | -$383 | ﹤0.01% | 4320 |
|
|
2025
Q1 | $1.59K | Sell |
278
-200
| -42% | -$1.14K | ﹤0.01% | 4406 |
|
|
2024
Q4 | $4.69K | Hold |
478
| – | – | ﹤0.01% | 4055 |
|
|
2024
Q3 | $3.9K | Sell |
478
-72
| -13% | -$587 | ﹤0.01% | 4111 |
|
|
2024
Q2 | $7.35K | Sell |
550
-397
| -42% | -$5.31K | ﹤0.01% | 3883 |
|
|
2024
Q1 | $44K | Buy |
947
+31
| +3% | +$1.44K | ﹤0.01% | 3050 |
|
|
2023
Q4 | $61.9K | Buy |
916
+114
| +14% | +$7.71K | ﹤0.01% | 2860 |
|
|
2023
Q3 | $58.1K | Buy |
802
+175
| +28% | +$12.7K | ﹤0.01% | 2874 |
|
|
2023
Q2 | $46.6K | Buy |
627
+49
| +8% | +$3.64K | ﹤0.01% | 3094 |
|
|
2023
Q1 | $30.7K | Sell |
578
-400
| -41% | -$21.3K | ﹤0.01% | 3261 |
|
|
2022
Q4 | $66.1K | Sell |
978
-152
| -13% | -$10.3K | ﹤0.01% | 2811 |
|
|
2022
Q3 | $142K | Buy |
1,130
+552
| +96% | +$69.4K | ﹤0.01% | 2311 |
|
|
2022
Q2 | $55K | Buy |
578
+284
| +97% | +$27K | ﹤0.01% | 2932 |
|
|
2022
Q1 | $47K | Buy |
294
+194
| +194% | +$31K | ﹤0.01% | 3142 |
|
|
2021
Q4 | $34K | Buy |
+100
| New | +$34K | ﹤0.01% | 3314 |
|